Can metallothionein be a useful molecular marker for selecting hepatocellular carcinoma patients for platinum-based chemotherapy?

Journal of Gastroenterology

Volumn 39, Issue 12, 2004, Pages 1228-1229

  Doki, Yuichiro ^a   Monden, Morito ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE; BRCA1 PROTEIN; BRCA2 PROTEIN; CADMIUM; CISPLATIN; GLYCOPROTEIN P; METALLOTHIONEIN; MOLECULAR MARKER; MULTIDRUG RESISTANCE PROTEIN; PLATINUM DERIVATIVE; PROTEIN P53;

CANCER CHEMOTHERAPY; DETOXIFICATION; EDITORIAL; GENE MUTATION; GENETIC DISORDER; HUMAN; IMMUNOHISTOCHEMISTRY; LIVER BIOPSY; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MICROSATELLITE INSTABILITY; PATIENT SELECTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSCRIPTION REGULATION; TUMOR GROWTH;

ANTINEOPLASTIC AGENTS; CARCINOMA, HEPATOCELLULAR; CISPLATIN; HUMANS; LIVER NEOPLASMS; METALLOTHIONEIN; PATIENT SELECTION; TUMOR MARKERS, BIOLOGICAL;

EID: 11344274667     PISSN: 09441174     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00535-004-1508-5     Document Type: Editorial

References (10)

1. Simpkins CO. Metallothionein in human disease. Cell Mol Boil (Noisy-le-grand) 2000;46:465-88.
2. Coyle P, Philcox JC, Carey LC, Rofe AM. Metallothionein: The multipurpose protein. Cell Mol Life Sci 2002;59:627-47.
3. Haq F, Mahoney M, Koropatnick J. Signaling events for metallothionein induction. Mutat Res 2003;533:211-26.
4. Masters BA, Kelly EJ, Quaife CJ, Brinster RL, Palmiter RD. Targeted distuption of metallothionein I and II genes increases sensitivity to cadmium. Proc Natl Acad Sci U S A 1994;91:584-8.
5. Theocharis SE, Margeli AP, Klijanienko JT, Kouraklis GP. Metallothionein expression in human neoplasia. Histopathology 2004;45:103-18.
6. Theocharis SE, Margeli AP, Koutselinis A. Metallothionein: A multifunctional protein from toxicity to cancer. Int J Biol Markers 2003;18:162-9.
7. Ghoshal K, Jacob ST. Regulation of metallothionein gene expression. Prog Nucleic Acid Res Mol Biol 2001;66:357-84.
8. Endo T, Yoshikawa M, Ebara M, Kato K, Sunaga M, Fukuda H, et al. Immunohistochemical metallothionein expression in hepatocellular carcinoma: Relation to tumor progression and chemoresistance to platinum agents. J Gastroenterol 2004;39: 1196-1201.
9. Tashiro-Itoh T, Ichida T, Matsuda Y, Satoh T, Sugiyama M, Tanaka Y, et al. Metallothionein expression and concentrations of copper and zinc are associated with tumor differentiation in hepatocellular carcinoma. Liver 1997;17:300-6.
10. Ioachim EE, Goussia AC, Agnantis NJ, Machera M, Tsianos EV, Kappas AM. Prognostic evaluation of metallothionein expression in human colorectal neoplasms. J Clin Pathol 1999;52:876-9.